Hepatocellular carcinoma in hepatectomized patients: Biologic and therapeutic implications

被引:1
|
作者
Makatsoris, T
Petsas, T
Tsamandas, AC
Pagoni, N
Papathanassiou, Z
Karavis, D
Karatza, C
Kardamakis, D
Kalofonos, H
机构
[1] Univ Patras, Sch Med, Dept Internal Med, GR-26110 Patras, Greece
[2] Univ Patras, Sch Med, Div Oncol, GR-26110 Patras, Greece
[3] Univ Patras, Sch Med, Dept Radiol, GR-26110 Patras, Greece
[4] Univ Patras, Sch Med, Div Pathol, GR-26110 Patras, Greece
[5] Univ Patras, Sch Med, Div Surg, GR-26110 Patras, Greece
关键词
hepatocellular carcinoma; hepatectomy; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The macroscopic and microscopic features of 60 hepatocellular carcinomas (HCC) were investigated and correlated with patients' disease-free survival Patients and Methods: The study included 60 HCCs removed, by partial hepatectomy, from an equal number of patients. In these tumors, several macroscopic and microscopic features were assessed, graded and correlated with disease-free survival. Results: HCCs begin as small, well differentiated tumors that have an increased proliferation rate and neovascularization. Vascular invasion, which is the strongest predictor of disease recurrence, correlated significant with tumor number and size, the predominant and worst degree of differentiation, and the apoptosis/mitosis ratio. In the absence of macroscopic or large vessel invasion, the largest tumor size (p=0.006), apoptosislmitosis ratio (p=0.03) and number of tumors (p=0.04) were independent predictors of disease-free survival. Conclusion: This study showed that, in humans, the prognosis of HCC depends on several biological factors. Aggressive biological behavior (vascular invasion and recurrence) correlated significantly with: a) alterations in the apoptosislinitosis ratio and b) architectural and cellular alterations.
引用
收藏
页码:3067 / 3073
页数:7
相关论文
共 50 条
  • [31] Preoperative mean corpuscular hemoglobin affecting long-term outcomes of hepatectomized patients with hepatocellular carcinoma
    Huang, Pinzhu
    Liu, Chunhong
    Li, Binkui
    Zheng, Yun
    Zou, Ruhai
    Huang, Jun
    Hu, Zemin
    Yuan, Yunfei
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (02) : 229 - 236
  • [32] The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
    Hou, Jiajie
    Zhang, Haiyan
    Sun, Beicheng
    Karin, Michael
    JOURNAL OF HEPATOLOGY, 2020, 72 (01) : 167 - 182
  • [34] Predicting Biologic Behavior of Hepatocellular Carcinoma on MRI
    Kalb, B.
    Becker-Weidman, D.
    Sharma, P.
    Kitajima, H.
    Chen, Z.
    Martin, D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
  • [35] Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma
    Tarao, K
    Rino, Y
    Takemiya, S
    Tamai, S
    Ohkawa, S
    Sugimasa, Y
    Miyakawa, K
    Morinaga, S
    Yoshida, M
    Shibuya, A
    Kokubu, S
    Kakita, A
    Endo, O
    INTERVIROLOGY, 2000, 43 (01) : 20 - 26
  • [36] Favorable Outcomes of Hepatectomy for Ruptured Hepatocellular Carcinoma: Retrospective Analysis of Primary R0-Hepatectomized Patients
    Uchiyama, Hideaki
    Minagawa, Ryosuke
    Itoh, Shinji
    Kajiyama, Kiyoshi
    Harimoto, Norifumi
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Shirabe, Ken
    Takenaka, Kenji
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2016, 36 (01) : 379 - 385
  • [37] Modified maximal thymectomy in patients with myasthenia gravis. Biologic and therapeutic implications
    Salakou, S.
    Tsamandas, A.
    Tsibri, E.
    Apostolakis, E.
    Bonikos, D.
    Papapetropoulos, T.
    Dougenis, D.
    JOURNAL OF NEUROLOGY, 2006, 253 : 104 - 105
  • [38] Modified maximal thymectomy in patients with myasthenia gravis. Biologic and therapeutic implications
    Salakou, S.
    Tsamandas, A. C.
    Tsihri, E.
    Papathanasopoulos, P.
    Apostolakis, E.
    Bonikos, D. S.
    Papapetropoulos, T.
    Petsas, T.
    Dougenis, D.
    LABORATORY INVESTIGATION, 2007, 87 : 301A - 301A
  • [39] Modified maximal thymectomy in patients with myasthenia gravis. Biologic and therapeutic implications
    Salakou, S.
    Tsamandas, A.
    Tsibri, E.
    Apostolakis, E.
    Bonikos, D.
    Papapetropoulos, T.
    Dougenis, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 254 - 255
  • [40] Modified maximal thymectomy in patients with myasthenia gravis. Biologic and therapeutic implications
    Salakou, S.
    Tsamandas, A. C.
    Tsibri, E.
    Papathanasopoulos, P.
    Apostolakis, E.
    Bonikos, D. S.
    Papapetropoulos, T.
    Petsas, T.
    Dougenis, D.
    MODERN PATHOLOGY, 2007, 20 : 301A - 301A